Trevor J. Hallam
Net Worth

Last updated:

What is Trevor J. Hallam net worth?

The estimated net worth of Dr. Trevor J. Hallam is at least $4,755,846 as of 14 Apr 2023. He owns shares worth $48,317 as insider, has earned $144,349 from insider trading and has received compensation worth at least $4,563,180 in Sutro Biopharma, Inc..

What is the salary of Trevor J. Hallam?

Dr. Trevor J. Hallam salary is $760,530 per year as Pres of Research & Chief Scientific Officer in Sutro Biopharma, Inc..

How old is Trevor J. Hallam?

Dr. Trevor J. Hallam is 66 years old, born in 1959.

What stocks does Trevor J. Hallam currently own?

As insider, Dr. Trevor J. Hallam owns shares in one company:

Company Title Shares Price per share Total value
Sutro Biopharma, Inc. (STRO) Pres of Research & Chief Scientific Officer 56,117 $0.86 $48,317

What does Sutro Biopharma, Inc. do?

Sutro Biopharma, Inc. operates as clinical stage drug discovery, development, and manufacturing company. It focuses on creating protein therapeutics for cancer and autoimmune disorders through integrated cell-free protein synthesis and site-specific conjugation platform, XpressCF+.The company's product candidates include STRO-001, an antibody-drug conjugate (ADC) directed against the cancer target CD74 for patients with multiple myeloma and non-Hodgkin lymphoma that is in Phase 1 clinical trials; and STRO-002, an ADC directed against folate receptor-alpha for patients with ovarian and endometrial cancers, which is in Phase 1 clinical trials. It has collaboration and license agreements with Merck Collaboration to develop research programs focusing on cytokine derivatives for cancer and autoimmune disorders; and Celgene Corporation to discover and develop bispecific antibodies and/or ADCs focused on the field of immuno-oncology. The company was formerly known as Fundamental Applied Biology, Inc. Sutro Biopharma, Inc. was incorporated in 2003 and is headquartered in South San Francisco, California.

STRO logo
STRO
Sutro Biopharma, Inc.
$0.86

Trevor J. Hallam insider trading

Sutro Biopharma, Inc.

Dr. Trevor J. Hallam has made 18 insider trades between 2019-2023, according to the Form 4 filled with the SEC.

The largest trade he's ever made was exercising 19,405 units of STRO stock on 14 Jan 2021. As of 14 Apr 2023 he still owns at least 56,117 units of STRO stock.

Transaction Date Security Shares Price per share Total value Source
Option
Restricted Stock Unit (RSU) 3,750 N/A N/A
Option
Common Stock 3,750 N/A N/A
Option
Restricted Stock Unit (RSU) 12,500 N/A N/A
Option
Common Stock 9,750 N/A N/A
Option
Common Stock 12,500 N/A N/A
Option
Restricted Stock Unit (RSU) 9,750 N/A N/A
Option
Common Stock 5,250 N/A N/A
Option
Restricted Stock Unit (RSU) 5,250 N/A N/A
Option
Common Stock 3,750 N/A N/A
Option
Restricted Stock Unit (RSU) 3,750 N/A N/A
Option
Common Stock 12,500 N/A N/A
Option
Restricted Stock Unit (RSU) 12,500 N/A N/A
Option
Common Stock 5,250 N/A N/A
Option
Restricted Stock Unit (RSU) 5,250 N/A N/A
Option
Common Stock 11,019 N/A N/A
Option
Restricted Stock Unit (RSU) 11,019 N/A N/A
Option
Common Stock 5,250 N/A N/A
Option
Restricted Stock Unit (RSU) 5,250 N/A N/A
Sale
Common Stock 2,393 $25.89 $61,955
Option
Employee Stock Option (right to buy) 2,393 N/A N/A
Sale
Common Stock 2,393 $25.89 $61,955
Option
Common Stock 2,393 $4.36 $10,433
Option
Employee Stock Option (right to buy) 19,405 $4.36 $84,606
Option
Common Stock 19,405 N/A N/A
Option
Common Stock 2,393 N/A N/A
Sale
Common Stock 2,393 N/A N/A
Option
Employee Stock Option (right to buy) 2,393 N/A N/A
Sale
Common Stock 2,393 $4.36 $10,433
Option
Common Stock 2,393 N/A N/A
Option
Employee Stock Option (right to buy) 2,393 N/A N/A
Option
Common Stock 16,751 $4.36 $73,034
Option
Employee Stock Option (right to buy) 16,751 $4.36 $73,034
Sale
Common Stock 16,751 N/A N/A
Option
Employee Stock Option (right to buy) 9,182 N/A N/A
Option
Common Stock 9,182 N/A N/A
Sale
Common Stock 975 $10.26 $10,006
Option
Restricted Stock Unit (RSU) 17,906 N/A N/A
Option
Common Stock 17,906 N/A N/A
Option
Common Stock 17,906 N/A N/A
Sale
Common Stock 975 N/A N/A
Sale
Common Stock 975 N/A N/A
Sale
Common Stock 975 N/A N/A
Sale
Common Stock 975 N/A N/A
Sale
Common Stocck 2 N/A N/A
Sale
Common Stock 973 N/A N/A
Sale
Common Stock 975 N/A N/A
Sale
Common Stock 975 N/A N/A
Sale
Common Stock 975 N/A N/A
Sale
Common Stock 975 N/A N/A
Sale
Common Stock 975 N/A N/A
Sale
Common Stock 975 N/A N/A
Option
Restricted Stock Unit (RSU) 17,906 N/A N/A
Option
Common Stock 17,906 N/A N/A

Sutro Biopharma key executives

Sutro Biopharma, Inc. executives and other stock owners filed with the SEC: